Dr Guraa Bergkvist

The Royal (Dick) School of Veterinary Studies/The Roslin Institute

Selected Publications

  • Mark Edmund Gray, Seungmee Lee, Ashleigh L. McDowell, Matthew Erskine, Q.T.M. Loh, Olivia Grice, David Argyle, Guraa Bergkvist. 2016. Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro. Veterinary and Comparative Oncology. More»
  • Guraa Bergkvist, Mark Edmund Gray, Monoar Pallab, Seungmee Lee, Maybelle Qian Ting Loh, David Argyle, Donald Yool. 2014. Targeting multiple oncogenes simultaneously improves response to therapy and circumvents acquired resistance to single target tyrosine kinase inhibitors. More»
  • G. T. Bergkvist, D. J. Argyle, Linda Morrison, Neil Macintyre, A. Hayes, D. A. Yool. 2011. Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC). Veterinary and Comparative Oncology Vol: 9 Pages: 106-117. More»
  • Guraa Bergkvist, David J. Argyle, Lisa Y. Pang, Rhona Muirhead, Donald A. Yool. 2011. Studies on the inhibition of feline EGFR in squamous cell carcinoma: Enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors. Cancer Biology & Therapy Vol: 11 Pages: 927-937. More»
  • Lisa Pang, Guraa Bergkvist, A Cervantes-Arias, Donald Yool, Rhona Muirhead, David Argyle. 2012. Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition.. The Veterinary Journal Vol: 193 Pages: 46-52. More»
  • G.T. Bergkvist, D.A. Yool. 2011. Epidermal growth factor receptor as a therapeutic target in veterinary oncology. Veterinary and Comparative Oncology Vol: 9 Pages: 81-94. More»